ELEVANCE HEALTH INC (ELV) Stock Income Statement
NYSE:ELV - New York Stock Exchange, Inc. - US0367521038 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 183.12B | 176.81B | 171.34B | 156.59B | 138.64B | |||
| Gross Premiums Earned | 181.70B | 175.20B | 170.21B | 155.66B | 136.94B | |||
| Loss Claims | 132.33B | 127.57B | 124.33B | 116.64B | 102.64B | |||
| Minority Interest Expense | 11.00M | 9.00M | -4.00M | 6.00M | 9.00M | |||
| Operating Expenses | 174.03B | 167.65B | 161.84B | 148.10B | 129.48B | |||
| Selling, General, and Administrative Expenses | N/A | N/A | N/A | 17.65B | 15.50B | |||
| Operating Income | 9.09B | 9.16B | 9.50B | 8.49B | 9.15B | |||
| Interest Income/Expense | -1.26B | -1.19B | -1.03B | -851.00M | -798.00M | |||
| Non Recurring Items | N/A | -67.00M | -752.00M | -39.00M | -432.00M | |||
| Income Before Taxes | 7.76B | 7.90B | 7.71B | 7.60B | 7.92B | |||
| Income Tax | 1.86B | 1.93B | 1.72B | 1.71B | 1.83B | |||
| Net Income | 5.92B | 5.98B | 5.99B | 5.89B | 6.10B | |||
| EBITDA | 10.53B | 10.55B | 11.24B | 10.16B | 10.46B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 25.63 | 25.68 | 25.22 | 24.28 | 24.73 | |||
| Non GAAP EPS | 34.30 | 32.97 | 33.11 | 29.05 | 25.97 | |||
| Statistics | ||||||||
| Profit Margin | 3.23% | 3.38% | 3.49% | 3.76% | 4.40% | |||
| Operating Profit Margin | 4.97% | 5.18% | 5.54% | 5.42% | 6.60% | |||
All data in USD